Merck (MRK) Misses Q2 EPS by 17c, Guidance Comes in Light
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $135.55 --0%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q2 EPS of $1.31, $0.17 worse than the analyst estimate of $1.48. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $11.7 billion.
GUIDANCE:
Merck sees FY2021 EPS of $5.47-$5.57, versus the consensus of $6.15. Merck sees FY2021 revenue of $46.4-47.4 billion, versus the consensus of $48.6 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
